Next |
home / stock / allr / allr message board
Subject | By | Source | When |
---|---|---|---|
It looks like its working out fine lmfao | INFINITI | investorshub | 07/05/2023 2:51:31 PM |
Hahaha what you think now | INFINITI | investorshub | 07/05/2023 2:51:07 PM |
AALR no 1 on the Barchart Top 100 | Monksdream | investorshub | 07/05/2023 2:47:34 PM |
https://finance.yahoo.com/news/initial-data-allarity-phase-2-134500446.html | surf1944 | investorshub | 07/05/2023 2:29:01 PM |
Its holding strong | INFINITI | investorshub | 06/29/2023 4:58:32 PM |
Not really we cant even hold pre split | ghosttrader13 | investorshub | 06/29/2023 4:38:12 PM |
Nice day so far | INFINITI | investorshub | 06/29/2023 3:31:49 PM |
Smh never seen it work out for anyone | ghosttrader13 | investorshub | 06/28/2023 4:20:50 PM |
The higher it goes the higher the split | INFINITI | investorshub | 06/28/2023 4:20:17 PM |
So buy here and after the split pray | ghosttrader13 | investorshub | 06/28/2023 4:19:50 PM |
Someones loading also nice | INFINITI | investorshub | 06/28/2023 4:19:47 PM |
Oh lol just saw it | INFINITI | investorshub | 06/28/2023 4:17:07 PM |
Yes there is! Its today at 4:05 lol | ghosttrader13 | investorshub | 06/28/2023 4:16:30 PM |
No date on that yet | INFINITI | investorshub | 06/28/2023 4:15:33 PM |
Buy before a 1:40 reverse split.... youd need | ghosttrader13 | investorshub | 06/28/2023 4:15:07 PM |
Ok your loss | INFINITI | investorshub | 06/28/2023 4:14:03 PM |
For what haha | ghosttrader13 | investorshub | 06/28/2023 4:13:39 PM |
Load up quick | INFINITI | investorshub | 06/28/2023 3:57:41 PM |
Whoa $$$$$$ | INFINITI | investorshub | 06/28/2023 3:56:59 PM |
Oh ok why is it showing | INFINITI | investorshub | 06/28/2023 3:47:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
Boston (May 20, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it has received formal written notice f...
- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved - On Track to Regain Compliance with All Nasdaq Listing Requirements - No Variable Priced Securities are Outstanding - Warrant Overhang Near Elimination - Allarity Withdraws its F...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...